Effect of doxapram (Dopram) and dimorpholamine (Theraptique) on arrhythmia an
Yasuda, I.; Iwatsuki, K.
Masui. Japanese Journal of Anesthesiology 23(11): 1067-1071
1974
ISSN/ISBN: 0021-4892 PMID: 4475120 Document Number: 77628
Document emailed within 1 workday
Related Documents
Hironaka, T. 1970: Effect of dimorpholamine (Th 1064) on crayfish neuromuscular junction Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 66(3): 293-303Gasser, J.C.; Bellville, J.W. 1975: The respiratory effect of doxapram and pentazocine and their interaction Der Anaesthesist 24(12): 526-528
Sokolov, S.F.; Golitsyn, S.P.; Malakhov, V.I.; Bankuzov, V.A.; Koltunova, M.I.; Golitsyn, L.S. 1990: The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor Farmakologiia i Toksikologiia 53(3): 57-60
Nakamura, H. 2004: Recent progress in molecular etiology of arrhythmia and anti-arrhythmia drug therapy Masui. Japanese Journal of Anesthesiology 53 Suppl: S81-S90
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123
Savina, M.D.; Kudrin, A.N. 1982: Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide Farmakologiia i Toksikologiia 45(2): 63-65
Lishmanov, I.B.; Maslov, L.N.; Krylatov, A.V.; Ugdyzhekova, D.S.; Gilligan, P.; Tam, S.W. 2000: The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands Eksperimental'naia i Klinicheskaia Farmakologiia 63(2): 39-43
Mazur, N.A.; Kurbanov, R.D. 1984: Deterioration in ventricular arrhythmia caused by anti-arrhythmia preparations Terapevticheskii Arkhiv 56(9): 67-70
Yazaki, Y.; Ohta, A.; Tsunakawa, H.; Harumi, K. 1984: Diagnosis of arrhythmia. a. Invasive arrhythmia analysis and provocation tests Nihon Rinsho. Japanese Journal of Clinical Medicine 42(12): 2676-2686
Hohnloser, S.H.; Meinertz, T.; Mehender, M.; Geibel, A.; Just, H. 1988: Induction and increase of cardiac arrhythmia by anti-arrhythmia agents Der Internist 29(5): 338-344
Bonhorst, D. 1992: Choice of anti-arrhythmia agents: the arrhythmia-patient binomial Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 387-389
Langer Damborenea, L. 1977: Our experience with doxapram hydrochloride Revista Espanola de Anestesiologia y Reanimacion 24(2): 180-185
Handa, S.; Mitamura, H. 1980: Arrhythmia and differential diagnosis: supraventricular arrhythmia Nursing Technique 26(2): 166-172
Tourreau, A.; Jeanneret, A.; Aiache, J.M.; Roche, G.; Roche, E.; Molina, C. 1978: Doxapram. Pharmocokinetic and clinical study Le Poumon et le Coeur 34(6): 431-435
Kenedi, I.; Losonci, A. 1973: Arrhythmia after left coronary ligation and the effect of isoproterenol in the rat Acta Physiologica Academiae Scientiarum Hungaricae 43(2): 133-141
Honerjäger, P. 1990: New aspects of the molecular effect of anti-arrhythmia agents Herz 15(2): 70-78
De Micheli, A.; Medrano, G.A.; Casanova, J.M. 1995: Effect of intravenous verapamil in experimental ventricular arrhythmia Archivos del Instituto de Cardiologia de Mexico 65(6): 484-495
Ishikawa, M.; Ozaki, M.; Takayanagi, Y.; Sasaki, K. 1991: Doxapram inhibits the in vitro oxidation of hexobarbital Research Communications in Chemical Pathology and Pharmacology 72(3): 371-374
Mest, H.J.; Blass, K.E.; Förster, W. 1976: The anti-arrhythmic effect of prostaglandins A1, E1, A2, E2 and F2a in the cat strophanthin arrhythmia model Acta Biologica et Medica Germanica 35(1): 63-67